Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration with Watchmaker Genomics, a supplier of innovative products for molecular ...
Federal regulators have authorized a new at-home test that can detect COVID-19, the flu, and other respiratory ailments. They say the test can help prevent the spread of these illnesses. They note, ...
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on the high throughput molecular diagnostic analysers ...
LONDON--(BUSINESS WIRE)--Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs ...
Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved ...
Roche has introduced the cobas Respiratory flex test, a new diagnostic that utilises the company's temperature-activated generation of signal (TAGS) technology. This is said to be the first instance ...
SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ --Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
Roche AG’s new test using its temperature-activated generation of signal technology is the next step in PCR evolution, Igor Kozlov, head of Reagent Research and Design at Roche Diagnostics Solutions, ...
For people with suspected community-acquired pneumonia (CAP) in the emergency department (ED), routine polymerase chain reaction (PCR) testing on lower respiratory tract samples led to faster and more ...
If proven to be accurate, the point-of-care test could provide the NHS with a highly scalable, low-cost diagnostic tool. It ...
Rapid test enters trial to diagnose winter respiratory infections: United Kingdom Wednesday, January 28, 2026, 18:00 Hrs [IST] An NIHR-supported trial is investigating whether a 6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results